News >

Immunotherapy Research Continues to Emerge in Urothelial Cancer

Ellie Leick
Published: Friday, Jul 12, 2019

Robert Dreicer, MD

Robert Dreicer, MD

Approximately one-quarter of patients with urothelial cancer respond to immunotherapy, a number that could increase with better methods to broaden response rates and improve patient selection, explained Robert Dreicer, MD.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication